🚀 VC round data is live in beta, check it out!

Bluelinea Valuation Multiples

Discover revenue and EBITDA valuation multiples for Bluelinea and similar public comparables like Nestmedic, Sds Optic, Scandinavian ChemoTech, AMA Corp and more.

Bluelinea Overview

About Bluelinea

Bluelinea SA is engaged in designing and developing of electronic surveillance and medical teleassistance systems.


Founded

2014

HQ

France

Employees

45

Financials (FY)

Revenue: $12M
EBITDA: $807K

EV

$15M

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Bluelinea Financials

Bluelinea reported last fiscal year revenue of $12M and EBITDA of $807K.

In the same fiscal year, Bluelinea generated $8M in gross profit, $807K in EBITDA, and had net loss of ($1M).


Bluelinea P&L

In the most recent fiscal year, Bluelinea reported revenue of $12M and EBITDA of $807K.

Bluelinea expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Bluelinea forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
RevenueXXX$12MXXXXXXXXX
Gross ProfitXXX$8MXXXXXXXXX
Gross MarginXXX72%XXXXXXXXX
EBITDAXXX$807KXXXXXXXXX
EBITDA MarginXXX7%XXXXXXXXX
EBIT MarginXXX(12%)XXXXXXXXX
Net ProfitXXX($1M)XXXXXXXXX
Net MarginXXX(13%)XXXXXXXXX
Net Debt$4MXXXXXXXXX

Financial data powered by Morningstar, Inc.

Bluelinea Stock Performance

Bluelinea has current market cap of $9M, and enterprise value of $15M.

Market Cap Evolution


Bluelinea's stock price is $0.52.

See Bluelinea trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$15M$9M-3.6%XXXXXXXXX$-0.08

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Bluelinea Valuation Multiples

Bluelinea trades at 1.3x EV/Revenue multiple, and 18.5x EV/EBITDA.

See valuation multiples for Bluelinea and 15K+ public comps

Bluelinea Financial Valuation Multiples

As of April 20, 2026, Bluelinea has market cap of $9M and EV of $15M.

Equity research analysts estimate Bluelinea's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Bluelinea has a P/E ratio of (6.3x).

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$9MXXX$9MXXXXXXXXX
EV (current)$15MXXX$15MXXXXXXXXX
EV/RevenueXXX1.3xXXXXXXXXX
EV/EBITDAXXX18.5xXXXXXXXXX
EV/EBITXXX(10.7x)XXXXXXXXX
EV/Gross ProfitXXX1.8xXXXXXXXXX
P/EXXX(6.3x)XXXXXXXXX
EV/FCFXXX(11.1x)XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Bluelinea Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Bluelinea Margins & Growth Rates

Bluelinea's revenue in the last fiscal year declined by (1%).

Bluelinea's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.

See operational valuation multiples for Bluelinea and other 15K+ public comps

Bluelinea Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue GrowthXXX(1%)XXXXXXXXX
EBITDA MarginXXX7%XXXXXXXXX
EBITDA GrowthXXX3569%XXXXXXXXX
Revenue per EmployeeXXX$0.3MXXXXXXXXX
Opex per EmployeeXXX$0.2MXXXXXXXXX
Opex to RevenueXXX84%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Bluelinea Public Comps

See public comps and valuation multiples for other Medical Devices comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
BluelineaXXXXXXXXXXXXXXXXXX
NestmedicXXXXXXXXXXXXXXXXXX
Sds OpticXXXXXXXXXXXXXXXXXX
Scandinavian ChemoTechXXXXXXXXXXXXXXXXXX
AMA CorpXXXXXXXXXXXXXXXXXX
ZynexXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Bluelinea M&A Activity

Bluelinea acquired XXX companies to date.

Last acquisition by Bluelinea was on XXXXXXXX, XXXXX. Bluelinea acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Bluelinea

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Bluelinea Investment Activity

Bluelinea invested in XXX companies to date.

Bluelinea made its latest investment on XXXXXXXX, XXXXX. Bluelinea invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Bluelinea

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Bluelinea

When was Bluelinea founded?Bluelinea was founded in 2014.
Where is Bluelinea headquartered?Bluelinea is headquartered in France.
How many employees does Bluelinea have?As of today, Bluelinea has over 45 employees.
Is Bluelinea publicly listed?Yes, Bluelinea is a public company listed on Euronext Paris.
What is the stock symbol of Bluelinea?Bluelinea trades under ALBLU ticker.
When did Bluelinea go public?Bluelinea went public in 2012.
Who are competitors of Bluelinea?Bluelinea main competitors are Nestmedic, Sds Optic, Scandinavian ChemoTech, AMA Corp.
What is the current market cap of Bluelinea?Bluelinea's current market cap is $9M.
What is the current revenue of Bluelinea?Bluelinea's last fiscal year revenue is $12M.
What is the current EV/Revenue multiple of Bluelinea?Current revenue multiple of Bluelinea is 1.3x.
Is Bluelinea profitable?No, Bluelinea is not profitable.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial